
    
      Single escalating doses of PER977 from 100 to 300 mg, of 25 mg PER977 x 4 doses will be
      administered following administration of enoxaparin. Serial pharmacokinetic and
      pharmacodynamic assessments ( whole blood clotting time) will be performed. Adverse events
      will be monitored.
    
  